AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Hybrid Breast Implants From Stem Cells and Biomaterials

Technology Benefits
-- Have been shown to maintain virtually 100% of original shape and dimension after in vivo implantation over a period of four weeks -- Facilitates integration with host tissue-- Reduces burden of engineering a large bulk of bioengineered material-- May reduce immunogenicity of implant
Technology Application
-- Cosmetic, plastic, and reconstructive procedures-- Examples: partial or whole breast, facial, pectoral, or calf augmentation
Detailed Technology Description
This technology uses stem cells and well-characterized biocompatible materials for the development of soft tissue implants that circumvent common complications found with traditional silicone or saline based implants. These hybrid implants retain th...
*Abstract
None
*Inquiry
Donna SeeColumbia Technology VenturesTel: (212) 854-8444Email: TechTransfer@columbia.edu
*IR
2194
*Principal Investigator
*Publications
Stosich et al. Plast Reconstr Surg. 2007 Jan;119(1):71-83.Alhadlaq et al. Tissue Eng 2005 (11):556-566.
*Web Links
WIPO: WO 2008/148026VIDEO PROFILE: JEREMY MAOPatent pending: US 2010/0305696 A1
Country/Region
USA

For more information, please click Here
Mobile Device